News & Releases

Thanks and Farewell to the Image Analysis Special Interest Group

By |2026-02-13T17:28:43+00:00February 19, 2026|Community News, Investigator Highlight|

The Image Analysis Special Interest Group has sunset after seven years. BIG THANK YOU to our Outgoing Image Analysis Special Interest Group Chairs - Clarence [...]

Comments Off on Thanks and Farewell to the Image Analysis Special Interest Group

🧰CCKP Toolkit Tool Feature: phangorn

By |2026-02-13T17:36:03+00:00February 13, 2026|CCKP, Tools|

phangorn is an R package for phylogenetic reconstruction and analysis. It supports Maximum Likelihood, Maximum Parsimony, distance-based methods, and Hadamard conjugation, enabling researchers to [...]

Comments Off on 🧰CCKP Toolkit Tool Feature: phangorn

Meet your new Data Manager Operation Group Chairs!

By |2026-01-15T21:59:06+00:00February 12, 2026|Community News, Investigator Highlight|

From its launch, the Data Manager Operations Group has been led by Aditi Gopalan, Bioinformatics Engineer in the MC2 Center Team. We are so excited [...]

Comments Off on Meet your new Data Manager Operation Group Chairs!

Meet your new Cell & Tissue Mechanics Special Interest Group Chairs!

By |2026-01-15T21:55:38+00:00February 4, 2026|Community News, Investigator Highlight|

I am a postdoctoral fellow at Memorial Sloan Kettering Cancer Center, studying how mechanical force influences cancer plasticity. As a new co-chair, I [...]

Comments Off on Meet your new Cell & Tissue Mechanics Special Interest Group Chairs!

BIG THANK YOU to our Outgoing Cell & Tissue Mechanics Special Interest Group Chairs – Meenal Datta and Wenjun Wang!

By |2026-01-15T21:54:39+00:00January 23, 2026|Community News, Investigator Highlight|

The MC2 Center team is so grateful and - we know the community benefitted so much from for your past two years of service! [...]

Comments Off on BIG THANK YOU to our Outgoing Cell & Tissue Mechanics Special Interest Group Chairs – Meenal Datta and Wenjun Wang!

📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma

By |2026-01-15T21:39:21+00:00January 15, 2026|CCKP, Data Features|

Targeted therapies for melanoma, like BRAF and MEK inhibitors, can shrink tumors but often fail to completely eliminate all cancer cells. A small group [...]

Comments Off on 📈New Dataset: NR2F1 underlies persistence of residual disease in BRAF-mutant melanoma
Go to Top